期刊文献+

microRNA与冠状动脉粥样硬化性心脏病的相关性研究 被引量:3

Association between microRNA and coronary artery disease
原文传递
导出
摘要 目的探讨miR-126,miR-130a,miR-222在冠心病患者外周血浆中的表达水平及其临床意义。方法选择冠心病患者79例(45例轻度组、34例重度组),冠状动脉阴性对照组24例,收集两组样本临床资料;运用Real-time PCR法检测样本血浆miR-126、miR-130a、miR-222表达水平;分析其表达差异及与脂蛋白a相关性,评估血浆miR-126、miR-130a、miR-222在冠心病中的表达水平及其临床意义。结果 (1)与对照组相比,冠心病组患者血浆miR-126和miR-222的表达水平降低和升高,分别是对照组的0.08倍和4.23倍,差异有统计学意义(P<0.05);miR-130a表达水平降低,是对照组的0.32倍,但差异无统计学意义(P>0.05)。(2)以改良Gensini评分对冠心病患者进行亚组分析,冠心病轻度组与重度组miR-126的表达水平分别为对照组的0.15倍及0.004倍,miR-222的表达水平分别为对照组的2.77倍及7.38倍,差异均有统计学意义(P<0.05),并且miR-126、miR-222表达水平变化与改良Gensini评分相关。(3)冠心病组中患者Lpa与miR-126、miR-130a、miR-222表达水平均无相关性。结论冠心病患者外周血浆中miR-126、miR-222表达水平较冠状动脉阴性对照组有显著差异,且表达水平变化与冠状动脉狭窄程度密切相关。 Objective To investigate the expression and clinical implication of peripheral plasma miR-126, miR-130a, miR-222 in patients with coronary artery disease(CAD). Methods 79 patients with CAD (CAD group: 45 mild, 34 severe) and 24 controls without CAD were included. General clinical data and related biochemical parameters were collected. Plasma miR-126, miR-130a, miR-222 levels were detected with quantitative real-time polymerase chain reaetion(qRT-PCR) analysis and the expression differences were analyzed. The correlation between miR-126, miR-130a, miR-222 and lipopmtein(a) were analyzed also. Results (1) Compared with control group, the expression level of plasma miR-126 was significantly decreased in CAD group (fold 0.08) and miR-222 was significantly increased in CAD group (fold 4.23)(P〈0.05); miR-130a was decreased (fold 0.32) (P〈0.05). (2) In CAD subgroup of improved Gensini method, the expression level of plasma miR-126 and miR-222 were significantly different in mild and severe group, miR-126 (mild with fold 0.15, severe with fold 0.004) (P〈0.05), miR-222 (mild with fold 2.77, severe with fold 7.23)(P〈0.05). The expression level changes of plasma miR-126 and miR-222 were closely related to improved Gensini scores. (3)There was no correlation between miR-126, miR-130a, miR-222 and lipoprotein(a) in CAD group (P〉0.05). Conclusion Compared with control group, the expression levels of peripheral plasma miR-126 and miR-222 were significant difference in patients with CAD. The expression level changes of plasma miR-126 and miR-222 were closely related to the severity of Coronary artery stenosis.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第24期39-42,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 上海市自然科学基金面上项目(12ZR1417400) 上海市教委优青项目(jdy11001) 上海交通大学医学院附属第三人民医院优青项目(11YYQ03)
关键词 冠心病 微RNAS 聚合酶链反应 Coronary disease MicroRNAs Polymerase chain reaction
  • 相关文献

参考文献11

  • 1Ying SY,Lin SL. Intron-mediated RNA interference and microRNA biogenesis[J].{H}Methods in Molecular Biology,2009.387-413.
  • 2Ajit SK. Circulating microRNAs as biomarkers,therapeutic targets,and signaling molecules[J].Sensors(basel),2012.3359-3369.
  • 3Santoro MM,Nicoli S. miRNAs in endothelial cell signaling:the endomiRNAs[J].{H}Experimental Cell Research,2013.1324-1330.
  • 4Sullivan DR,Marwick TH,Freedman SB. A new method of scoring comnary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors[J].{H}American Heart Journal,1990.1262-1267.
  • 5Staszel T,Zapala B,Polus A. Role of microRNAs in endothelial cell pathophysiology[J].Pol Arch Med Ween,2011.361-366.
  • 6Wang S,Aurora AB,Johnson BA. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis[J].{H}Developmental Cell,2008.261-271.
  • 7Harris TA,Yamakuchi M,Ferlito M. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1[J].{H}Proceedings of the National Academy of Sciences(USA),2008.1516-1521.
  • 8Zhu H,Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling[J].{H}Cardiovascular Research,2012.284-292.
  • 9Chen Y,Gorski DH. Regulation of angiogenesis through a microRNA(miR-130a)that down-regulates antiangiogenic homeobox genes GAX and HOXA5[J].{H}Blood,2008.1217-1226.
  • 10Poliseno L,Tuccoli A,Mariani L. MicroRNAs modulate the angiogenic properties of HUVECs[J].{H}Blood,2006.3068-3071.

同被引文献20

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部